An enhanced CRISPR repressor for targeted mammalian gene regulation
Nan Cher Yeo,Alejandro Chavez,Alissa Lance-Byrne,Yingleong Chan,Yingleong Chan,David J. Menn,Denitsa Milanova,Denitsa Milanova,Chih-Chung Kuo,Xiaoge Guo,Xiaoge Guo,Sumana Sharma,Angela Tung,Ryan J Cecchi,Marcelle Tuttle,Swechchha Pradhan,Elaine T. Lim,Elaine T. Lim,Noah Davidsohn,Noah Davidsohn,Mo R. Ebrahimkhani,Mo R. Ebrahimkhani,James J. Collins,Nathan E. Lewis,Samira Kiani,George M. Church,George M. Church +26 more
TL;DR: An improved Cas9 repressor based on the C-terminal fusion of a rationally designed bipartite repressor domain, KRAB–MeCP2, to nuclease-dead Cas9 is described, demonstrating the system’s superiority in silencing coding and noncoding genes and enabling new architectures of synthetic genetic circuits.
read more
Abstract: The RNA-guided endonuclease Cas9 can be converted into a programmable transcriptional repressor, but inefficiencies in target-gene silencing have limited its utility. Here we describe an improved Cas9 repressor based on the C-terminal fusion of a rationally designed bipartite repressor domain, KRAB-MeCP2, to nuclease-dead Cas9. We demonstrate the system's superiority in silencing coding and noncoding genes, simultaneously repressing a series of target genes, improving the results of single and dual guide RNA library screens, and enabling new architectures of synthetic genetic circuits.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Transcription factor engineering in CHO cells for recombinant protein production.
Matías Gutiérrez-González,Yesenia Latorre,Roberto Zúñiga,Juan Carlos Aguillón,María Carmen Molina,Claudia Altamirano +5 more
TL;DR: The strategies to increase recombinant protein expression by modulating and designing TFs and with advancements in synthetic biology are summarized and it is illustrated how this class of proteins can be used to develop more robust expression systems.
22
CRISPR interference and its applications.
TL;DR: This chapter discusses CRISPRi structure, mechanism and its applications.
21
An autoimmune disease risk variant has a trans master regulatory effect mediated by IRF1 under immune stimulation
Margot Brandt,Sarah Kim-Hellmuth,Marcello Ziosi,Alper Gokden,Aaron Wolman,Nora Lam,Yocelyn Recinos,Veit Hornung,Johannes Schumacher,Tuuli Lappalainen +9 more
TL;DR: This work provides evidence of the causal variant, demonstrates a condition-specific enhancer effect, identifies IRF1 as the likely causal gene in cis, and indicates that overactivation of the downstream immune-related pathway may be the cellular mechanism increasing disease risk.
Transcriptional enhancers: from prediction to functional assessment on a genome-wide scale.
Ian C Tobias,Luis E. Abatti,Sakthi D Moorthy,Shanelle Mullany,Tiegh Taylor,Nawrah Khader,Mario A Filice,Jennifer A. Mitchell +7 more
TL;DR: Experimental systems and techniques reviewed that have improved the ability to both observe and manipulate enhancers in vitro at the level of primary genetic sequences, chromatin states and spatial interactions broaden the understanding of enhancer function in development, evolution, and disease.
20
Genetically Engineering the Nervous System with CRISPR-Cas.
Alfredo Sandoval,Hajira Elahi,Jonathan E. Ploski +2 more
- 24 Feb 2020
TL;DR: An overview of the canonical function of the CRISPR platform is presented, followed by a functional review of its many adaptations, with an emphasis on its applications for genetic interrogation of the normal and diseased nervous system.
References
Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method
TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.
168.2K
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek,Krzysztof Chylinski,Krzysztof Chylinski,Ines Fonfara,Michael H. Hauer,Jennifer A. Doudna,Emmanuelle Charpentier +6 more
TL;DR: This study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.
16.2K
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong,Le Cong,F. Ann Ran,F. Ann Ran,David M. Cox,David M. Cox,Shuailiang Lin,Shuailiang Lin,Robert P. J. Barretto,Naomi Habib,Patrick D. Hsu,Patrick D. Hsu,Xuebing Wu,Wenyan Jiang,Luciano A. Marraffini,Feng Zhang +15 more
TL;DR: The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage as discussed by the authors.
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong,F. A. Ran,David Benjamin Turitz Cox,Shuailiang Lin,Robert P. J. Barretto,Naomi Habib,Patrick D. Hsu,Xuebing Wu,Wenyan Jiang,Luciano A. Marraffini,Feng Zhang +10 more
- 01 Feb 2013
TL;DR: Two different type II CRISPR/Cas systems are engineered and it is demonstrated that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.
12K
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali,Luhan Yang,Kevin M. Esvelt,John Aach,Marc Güell,James E. DiCarlo,Julie E. Norville,George M. Church,George M. Church +8 more
TL;DR: The type II bacterial CRISPR system is engineer to function with custom guide RNA (gRNA) in human cells to establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.